Lindsey Trickett
Investor Relations Contact bei F-STAR THERAPEUTICS, INC.
Aktive Positionen von Lindsey Trickett
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - | - |
Karriereverlauf von Lindsey Trickett
Ehemalige bekannte Positionen von Lindsey Trickett
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | 07.09.2017 | - |
Ausbildung von Lindsey Trickett
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Investor Relations Contact | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Lindsey Trickett
- Erfahrung
